Overview
- 31 inspections across 31 sites are on record.
- 68 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-06-30.
At a glance
Inspections
31
Sites
31
Observations
68
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Carlsbad Technology, Inc | 30 Jun 2026 | Human Drugs | View 483 → |
| YUNG SHIN PHARM. IND. CO., LTD. | 25 Apr 2024 | Human Drugs | On file |
| Sun Pharmaceutical Industries Ltd. | 13 Dec 2019 | Human Drugs | View 483 → |
| Zhejiang Shenzhou Pharmaceutical Co., Ltd. | 8 Jun 2018 | Human Drugs | |
| Zhejiang Supor Pharmaceuticals Co., LTD | 1 Jun 2018 | Human Drugs |
Sites inspected
Carlsbad Technology, IncCarlsbad, United States1 insp.
YUNG SHIN PHARM. IND. CO., LTD.Taichung City, Taiwan1 insp.
Sun Pharmaceutical Industries Ltd.Halol, India1 insp.
Zhejiang Shenzhou Pharmaceutical Co., Ltd.Taizhou, China1 insp.
Zhejiang Supor Pharmaceuticals Co., LTDShaoxing, China1 insp.
Co-investigators
Investigators who share inspections with this person.
Uduak M Inokon4 shared
Harry J Brewer4 shared
Michael A Taylor3 shared
Sangeeta M Khurana3 shared
Carla J Lundi3 shared
Michele L Forster3 shared
Simone E Pitts3 shared
William A Warnick3 shared
Vlada Matusovsky2 shared
Ngozi G Offor1 shared
Full investigator report
Get the verbatim findings behind Dongping Dai's 68 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site